Linked Life Data

7571774

Source:http://linkedlifedata.com/resource/pubmed/id/7571774

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1995-11-9
pubmed:abstractText
Radiofrequency catheter ablation has been established as a first line therapy for the curative treatment of patients with atrioventricular nodal reentrant tachycardia and atrioventricular tachycardia encompassing accessory pathways as well as for ablation of the "normal" AV-junction. For these indications, the success rates exceed 90%. Acute complications during ablation of accessory pathway and ablation of the "normal" AV-junction occur in approximately 2-5% of patients treated. The incidence of complications during modification of the atrioventricular node to cure AV-nodal reentrant tachycardias clearly depends on the ablation technique used. The anterior approach with ablation of the so-called "fast pathway" carries a significantly higher risk of complete AV-block when compared to the inferior approach (so-called "slow pathway ablation") (approximately 4-8% vs. 2%). Arrhythmia recurrence after successful ablation of the "normal" AV-junction occurs only rarely, while the recurrence rate after modification of the AV-node or ablation of accessory pathway is approximately 10% during long-term follow-up. Recently, it has been shown that other, rare types of supraventricular tachycardia (sinus-atrial reentrant tachycardia, ectopic atrial tachycardia, human type I atrial flutter) can also be successfully ablated using radiofrequency current. In addition, first clinical results indicate that modification of anterograde AV-nodal conduction properties in patients with atrial fibrillation and fast ventricular rate by radiofrequency application to postero- and midseptal sites might be a useful therapeutic tool to slow ventricular rate. Because of the high success-rate and the relative low incidence of severe procedure related complications, the indications of radiofrequency ablation procedures for the treatment of supraventricular tachycardias will be extended in the future. In addition, it might be reasonable to expect that during the next years, all types of supraventricular tachycardia, except atrial fibrillation, can be targeted and cured by radiofrequency ablation in the majority of cases.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0300-5860
pubmed:author
pubmed:issnType
Print
pubmed:volume
84 Suppl 2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
103-21
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
[High frequency current catheter ablation in treatment of supraventricular and atrioventricular tachycardia].
pubmed:affiliation
Medizinische Klinik und Poliklinik, Universitätsklinik Münster.
pubmed:publicationType
Journal Article, English Abstract, Review